Inaktiver Wert

Ambit Biosciences Corp Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	11.11.14
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	28.10.14
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14.10.14
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	01.10.14
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	01.10.14

Manager	Titel	Alter	Seit
Ken Takeshita CEO	Chief Executive Officer	-	-

Aufsichtsräte	Titel	Alter	Seit
Kenneth Joseph Keller BRD	Director/Board Member	61	10.11.14
Michael Martino CEO	Chief Executive Officer	68	16.11.11
Glenn Gormley BRD	Director/Board Member	-	10.11.14

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	-3.45%	87.17 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	40.1 Mrd.
BIOGEN INC.	-16.98%	31.38 Mrd.
UCB	+57.86%	25.12 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-16.24%	15.59 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	12 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.8 Mrd.
INCYTE CORPORATION	-17.10%	11.8 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+6.89%	8.81 Mrd.